Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 17, 2007

BioServe and NeoCodex Combine Offerings

  • Bioserve and NeoCodex entered a joint distribution deal through which collaborators working with both companies will gain expanded access to human samples.

    Under this agreement, BioServe will be able to provide clinically annotated human specimens from the homogenous Spanish population. NeoCodex reportedly has a nationwide network capable of acquiring DNA, FFPE’s (fixed-formalin paraffin-embedded tissue), fluids, and tissues.

    In return, NeoCodex gains access to BioServe’s Global Repository, a library of over 600,000 human DNA, tissue, and serum samples linked to clinical and demographic data from 140,000 consented and anonymized patients collected from four continents.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »